EN INVESTORS Investors Overview MOST RECENT PRESENTATION PRESENTATION ALL PRESENTATIONS COVID-19 INFORMATION AND RESOURCES Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus. READ MORE MOST RECENT EVENT 12/01/2021 4TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE ALL EVENTS TRANSCRIPT (OPENS IN NEW WINDOW) WEBCAST (OPENS IN NEW WINDOW) LATEST NEWS 11/25/2021 PFIZER AND BIONTECH RECEIVE POSITIVE CHMP OPINION FOR COMIRNATY® IN CHILDREN 5 TO UNDER 12 YEARS OF AGE IN THE EUROPEAN UNION 11/24/2021 PFIZER INVITES PUBLIC TO VIEW AND LISTEN TO WEBCAST OF PFIZER DISCUSSION AT HEALTHCARE CONFERENCE 11/22/2021 FOLLOW-UP DATA FROM PHASE 3 TRIAL OF PFIZER-BIONTECH COVID-19 VACCINE SUPPORT SAFETY AND HIGH EFFICACY IN ADOLESCENTS 12 THROUGH 15 YEARS OF AGE ALL NEWS INVESTOR RESOURCES GOVERNANCE STOCK FAQ TEAR SHEET EMAIL ALERTS VIATRIS TRANSACTION READ MORE 2020 ANNUAL REVIEW 2020 ESG REPORT ALL ANNUAL DOCUMENTS CURRENT STOCK PRICE $53.45 1.24 Dec 02, 2021 02:09 PM % Change 2.26% Day High $55.08 52 Wk. High $55.70 52 Wk. Low $33.36 VIEW MORE Q3 2021 EARNINGS PRESS RELEASE PRESENTATION PREPARED REMARKS TRANSCRIPT SEC FILINGS WEBCAST INFOGRAPHIC ALL RESULTS EMAIL ALERTS SEC FILINGS EVENTS & PRESENTATIONS END OF DAY STOCK QUOTE NEWS MOST RECENT EARNINGS MATERIALS Loading... Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.